Glenmark Pharmaceuticals Ltd

NSE :GLENMARK   BSE :532296  Sector : Pharmaceuticals
Buy, Sell or Hold GLENMARK? Ask The Analyst

BSE

prev close

OPEN PRICE

bid price (qty)

offer price (qty)

volume

Today's low / high

52 WK low / high

NSE

prev close

open price

bid price (qty)

offer price (qty)

volume

Today's' low / high

52 WK low / high

08 May
1021.50
(0.57%)
07 May
1015.75
(-2.39%)
06 May
1040.65
(-1.20%)
03 May
1053.30
(-0.68%)
02 May
1060.50
(0.31%)
30 Apr
1057.20
(-1.30%)
29 Apr
1071.10
(-0.76%)
26 Apr
1079.35
(-0.09%)
25 Apr
1080.30
(0.87%)
24 Apr
1070.95
(3.52%)
23 Apr
1034.50
(-0.47%)
22 Apr
1039.35
(1.26%)
19 Apr
1026.40
(-1.48%)
18 Apr
1041.80
(-1.72%)
16 Apr
1060.00
(1.53%)
15 Apr
1044.00
(-0.74%)
12 Apr
1051.80
(0.81%)
10 Apr
1043.35
(-0.35%)
09 Apr
1047.00
(0.76%)
08 Apr
1039.10
(2.13%)
05 Apr
1017.40
(1.13%)

Price Chart Historical Data Technical Chart

Technical Analysis

Short Term Investors

Very Bearish
Medium Term Investors

Bullish
Long Term Investors

Very Bullish

Moving Averages

5 DMA
Bearish

1038.34

10 DMA
Bearish

1055.04

20 DMA
Bearish

1048.71

50 DMA
Bullish

985.29

100 DMA
Bullish

923.99

200 DMA
Bullish

854.34


Intraday Support and Resistance
(Based on Pivot Points) |

Updated On May 08, 2024 04:00 PM For Next Trading Session

Pivots Classic Fibonacci Camarilla Woodie DM
R3 1052.76 1041.13 1027.4 - -
R2 1041.13 1032.94 1025.43 1041.59 -
R1 1031.31 1027.87 1023.47 1032.23 1036.23
P 1019.68 1019.68 1019.68 1020.14 1022.14
S1 1009.86 1011.49 1019.53 1010.78 1014.78
S2 998.23 1006.42 1017.57 998.69 -
S3 988.41 998.23 1015.6 - -

Key Metrics

EPS

37.29

P/E

27.37

P/B

1.57

Dividend Yield

0.24%

Market Cap

28,826 Cr.

Face Value

1

Book Value

651.23

ROE

6.91%

EBITDA Growth

-122.2 Cr.

Debt/Equity

0.46

Shareholding Pattern

  46.64% Total Promoter Holding
10.55% Mutual Fund Holdings
21.38% FIIs
18.58% Non Institution
2.25% Insurance Companies
0% Custodians
0.6% Other Parties

Shareholding History

Quarterly Result (Figures in Rs. Crores)


Glenmark Pharmaceuticals Ltd Quaterly Results


Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
INCOME 3309.61 3333.5 3055.79 3327.81 2670.88
PROFIT 148.51 204.3 182.37 68.79 -393.41
EPS 9.66 -15.18 5.31 -2.9 -12.45

Glenmark Pharmaceuticals Ltd Quaterly Results


Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
INCOME 2413.7 2172.01 2193.75 2306.99 1623.91
PROFIT 311.75 436.25 293.58 317.62 4.87
EPS 15.26 -4.87 9.63 10.72 -0.72

Profit & Loss (Figures in Rs. Crores)


Glenmark Pharmaceuticals Ltd Profit & Loss


Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023
INCOME 6044.41 6943.01 7721.83 9576.39 9032.11 10299.46 10705.37 11227.94 12482.71 13631.99
PROFIT 542.28 263.52 743.05 1155.03 805.34 818.68 755.72 941.32 1107.67 561.19
EPS 20.12 7.3 26.33 39.29 28.49 32.78 27.5 34.38 35.21 13.37

Glenmark Pharmaceuticals Ltd Profit & Loss


Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023
INCOME 2466.22 5358.49 6306 8220.99 5709.21 6787.67 7289.2 8032.82 9202.67 9237.97
PROFIT 433.99 1139.79 1484.9 2322 1016.26 1344.95 1340.12 1589.58 1643.77 1578.33
EPS 15.66 36.72 52.6 75.86 35.95 57.49 48 58.46 70.8 42.84

Balance Sheet (Figures in Rs. Crores)

Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014
SOURCES OF FUNDS :
Share Capital 28.2228.2228.2228.2228.2228.2228.2228.2227.1327.12
Reserves Total 9,445.719,058.437,036.416,042.295,576.975,135.264,464.313,601.421,756.362,956.16
Total Shareholders Funds9,473.939,086.657,064.636,070.515,605.195,163.484,492.533,629.641,783.492,983.28
Minority Interest365.34351.47-0.35-0.39-0.38-0.37-0.42-0.3-0.1913.28
Secured Loans 00006.1119.742.5915.5336.69353.32
Unsecured Loans 4,627.243,962.024,985.724,868.634,442.564,619.644,721.063,972.583,763.242,913.66
Total Debt4,627.243,962.024,985.724,868.634,448.674,639.384,723.653,988.113,799.933,266.98
Other Liabilities397.59152.5196.68429.2789.142.632.7476.99121.9252.13
Total Liabilities14,864.113,552.6412,246.6811,368.0210,142.629,805.099,248.57,694.445,705.156,315.67
APPLICATION OF FUNDS :
Gross Block 11,296.0610,213.478,731.588,269.836,527.275,367.954,769.924,300.543,495.473,833.51
Less: Accumulated Depreciation5,093.684,326.233,602.733,241.282,857.012,338.42,014.831,706.991,480.09742.96
Net Block6,202.385,887.245,128.855,028.553,670.263,029.552,755.092,593.552,015.383,090.55
Capital Work in Progress1,251.261,009.871,381.671,221.891,398.941,121.87708.11542.8477.135.34
Investments 44.6549.6224.6324.5929.6614.6615.6917.217.120
Inventories 2,977.792,499.832,276.832,135.622,252.072,030.592,139.051,567.761,269.04932.88
Sundry Debtors 4,098.613,101.142,572.062,408.962,194.592,331.812,404.322,492.652,511.772,156.34
Cash and Bank Balance1,469.71,411.521,139.161,111.24937.771,234.691,057.66857.12775.88800.67
Loans and Advances 1,327.631,269.871,371.541,147.781,312.41,391.611,273.61986.77774.38872.8
Total Current Assets9,873.728,282.357,359.586,803.616,696.836,988.696,874.645,904.35,331.074,762.69
Current Liabilities 3,851.522,914.642,763.72,744.432,662.082,357.822,252.412,364.422,334.381,850.9
Provisions 613.12584.5564.45555.91484.11432.46262.95134.03216.78259.95
Total Current Liabilities & Provisions4,464.643,499.143,328.163,300.343,146.182,790.282,515.362,498.442,551.162,110.86
Net Current Assets5,409.084,783.214,031.423,503.273,550.654,198.414,359.273,405.862,779.912,651.83
Deferred Tax Assets2,090.61,969.551,852.181,770.851,761.631,728.581,553.351,274.96169.73721.3
Deferred Tax Liability327.64314.93346.26331.59378.68408.32242.08210.07222.52207.08
Net Deferred Tax1,762.961,654.621,505.921,439.261,382.951,320.261,311.271,064.89-52.79514.22
Other Assets193.75168.08174.18150.45110.16120.3499.0670.15468.4253.72
Total Assets14,864.0813,552.6512,246.6711,368.0110,142.619,805.099,248.497,694.445,705.166,315.66
Contingent Liabilities336.69361.31384.2271.2173.5147.136.8836.89129.37129.44
Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014
SOURCES OF FUNDS :
Share Capital 28.2228.2228.2228.2228.2228.2228.2228.2227.1327.12
Reserves Total 17,849.2516,710.3714,781.2913,198.0511,913.8710,363.229,408.47,337.754,924.922,878.9
Total Shareholders Funds17,877.4716,738.5914,809.5113,226.2711,942.0910,391.449,436.627,365.974,952.052,906.02
Secured Loans 00006.1119.742.5915.5336.691.47
Unsecured Loans 3,221.223,737.73,703.993,573.763,128.372,961.332,773.94771.89373.41351.85
Total Debt3,221.223,737.73,703.993,573.763,134.482,981.072,776.53787.42410.1353.32
Other Liabilities372.58121.32136.61205.6588.512.62.414.7121.9251.88
Total Liabilities21,471.2720,597.6118,650.1117,005.6815,165.0813,375.1112,215.568,158.095,484.073,311.22
APPLICATION OF FUNDS :
Gross Block 3,183.653,026.282,848.562,595.062,260.12,581.752,368.532,107.041,801.98658.02
Less : Accumulated Depreciation 1,437.71,273.951,126.07983.11846.62882.63772.16669.04571.3209.5
Net Block 1,745.951,752.331,722.491,611.951,413.481,699.121,596.371,4381,230.68448.52
Capital Work in Progress172.34109.04131.4200.01286.2419.68270.66276.06294.1983.31
Investments 10,334.018,559.396,989.954,713.933,268.753,212.681,866.71,858.431,659.521,409.24
Inventories 1,090.21951.66762.39837.5911.211,111.181,145.06968736.63210.43
Sundry Debtors 2,505.662,678.322,488.751,835.242,087.133,828.913,879.43,057.662,440.831,136.04
Cash and Bank Balance93.7929.6315.7988.26256.48177.38252.1874.2448.55108.46
Loans and Advances 695.51743.311,642.21,662.891,886.33757.78674.19528.03371.94154.69
Total Current Assets4,385.184,402.934,909.124,423.895,141.155,875.255,950.834,627.933,597.951,609.61
Current Liabilities 2,952.142,168.391,834.311,827.481,855.861,796.561,727.021,867.561,882.99786.32
Provisions 162.52148.49133.11118.45121.7593.257.9787.37151.3895.64
Total Current Liabilities & Provisions3,114.662,316.881,967.411,945.921,977.621,889.761,784.981,954.932,034.37881.96
Net Current Assets1,270.522,086.052,941.712,477.973,163.543,985.494,165.852,672.991,563.58727.65
Deferred Tax Assets1,160.251,137.471,118.721,081.341,063.231,056.45820.62589.4124.8410.26
Deferred Tax Liability213.5214.2265.43276.6351.1395.83226.56188.25157.2346.67
Net Deferred Tax946.75923.27853.29804.74712.13660.62594.06401.16-132.39-36.41
Other Assets7,001.77,167.546,011.277,197.086,320.983,397.523,721.921,511.43868.49678.91
Total Assets21,471.2620,597.6218,650.1117,005.6815,165.0813,375.1112,215.568,158.085,484.073,311.21
Contingent Liabilities3,443.33,325.063,730.174,430.593,680.944,549.63,720.764,594.015,326.653,284.76

Cash Flow (Figures in Rs. Crores)

Net Profit before Tax and Extr...868.45
Depreciation611.27
Interest (Net)326.82
Dividend Received0.35
P/L on Sales of Assets-5.73
Prov. and W/O (Net)53.52
P/L in Forex-286.16
Total Adjustments (PBT and Ext...1,471.96
Operating Profit before Workin...2,340.41
Trade and 0ther Receivables-848.74
Inventories-375.17
Trade Payables166.21
Total Adjustments (OP before W...-1,074.48
Cash Generated from/(used in) ...1,265.93
Direct Taxes Paid-640.54
Total Adjustments(Cash Generat...-640.54
Cash Flow before Extraordinary...625.39
Net Cash from Operating Activi...625.39
Purchased of Fixed Assets-607.76
Sale of Fixed Assets57.23
Purchase of Investments-6.01
Sale of Investments5
Interest Received22.77
Net Cash used in Investing Act...-515.44
Proceed from 0ther Long Term B...1,163.19
On Redemption of Debenture-152.73
Of the Long Tem Borrowings-513.22
Of the Short Term Borrowings-20
Of Financial Liabilities-106.55
Dividend Paid-136.61
Interest Paid-311.54
Net Cash used in Financing Act...-77.46
Net Profit before Tax and Extr...1,571.87
Depreciation184.15
Interest (Net)22.68
Dividend Received320.09
P/L on Sales of Assets-5.63
Prov. and W/O (Net)25.02
P/L in Forex-279.51
Others-152.73
Total Adjustments (PBT and Ext...122.48
Operating Profit before Workin...1,694.35
Trade and 0ther Receivables141.32
Inventories-138.55
Trade Payables149.79
Total Adjustments (OP before W...196.13
Cash Generated from/(used in) ...1,890.48
Direct Taxes Paid-416.42
Total Adjustments(Cash Generat...-416.42
Cash Flow before Extraordinary...1,474.06
Net Cash from Operating Activi...1,474.06
Purchased of Fixed Assets-189.62
Sale of Fixed Assets316.54
Sale of Investments5
Interest Received313.19
Invest.In Subsidiaires-3.12
Loans to Subsidiaires-1,193.44
Net Cash used in Investing Act...-431.52
Of the Long Tem Borrowings-513.22
Of the Short Term Borrowings-20
Of Financial Liabilities-32.31
Dividend Paid-70.43
Interest Paid-189.81
Net Cash used in Financing Act...-978.5

Company Details

Registered Office
AddressB/2 Mahalaxmi Chambers,
22 Bhulabhai Desai Road
CityMumbai
StateMaharashtra
Pin Code400026
Tel. No.91-22-40189999
Fax. No.91-22-40189986
Emailcomplianceofficer@glenmarkpharma.com
Internethttp://www.glenmarkpharma.com
Registrars
AddressB/2 Mahalaxmi Chambers
CityMumbai
StateMaharashtra
Pin Code400026
Tel. No.91-22-40189999
Fax. No.91-22-40189986
Emailcomplianceofficer@glenmarkpharma.com
Internethttp://www.glenmarkpharma.com
Management
Name Designation
Glenn SaldanhaChairman / Executive Director / M D / Promoter
Cheryl PintoExecutive Director (Corporate)
V S ManiExecutive Director & Group CFO
B E SaldanhaNon Executive Director
Rajesh Desai.Independent Non Exe. Director
Devendra Raj MehtaIndependent Non Exe. Director
Bernard MunosIndependent Non Exe. Director
Brian W TempestIndependent Non Exe. Director
Sridhar GorthiIndependent Non Exe. Director
Sona Saira RamasastryIndependent Non Exe. Director
Dipankar BhattacharjeeIndependent Non Exe. Director
V R IyerIndependent Non Exe. Director